|
|
||||||||
Journal of Lipid Research, Vol 31, 859-869, Copyright © 1990 by Lipid Research, Inc.
ARTICLES |
PM Nishina, J Verstuyft and B Paigen
Children's Hospital Oakland Research Institute, Children's Hospital Medical Center, Oakland, CA 94609.
Diets currently used to produce atherosclerotic lesions in mice are often undefined and cause accumulation of fat in the liver and gallstone formation. Therefore, synthetic low and high fat diets of known composition were formulated in this study. A synthetic diet containing 50% sucrose, 15% cocoa butter, 1% cholesterol, and 0.5% sodium cholate was found to produce a depression in high density lipoprotein cholesterol (HDL-C) and an elevation of very low density lipoprotein (VLDL) and low density lipoprotein cholesterol (LDL-C) in the atherosclerosis-susceptible strain, C57BL/6J. This diet was able to consistently produce aortic lesions and led to a decrease in liver damage and gallstone formation. The synthetic low fat diet did not produce HDL-C levels as high as those found in mice fed chow, but resulted in similar VLDL/LDL-C levels. Lipoprotein and apolipoprotein parameters were compared in C57BL/6J and the atherosclerosis-resistant strain, C3H/HeJ, consuming the synthetic low fat or high fat diets. As reported earlier, when consuming a high fat diet C57BL/6J mice have significantly lower HDL-C and apoA-I levels than C3H/HeJ mice. Further analysis shows that the molar ratio of plasma HDL-C to apoA-I is significantly lower in C57BL/6J mice, suggesting that HDL in the susceptible strain has a lower cholesterol-carrying capacity. This conclusion is consistent with the observation that the HDL particle size is smaller for C57BL/6J mice than for C3H/HeJ. Both strains increased their apoE levels when fed the synthetic high fat diet, but C3H/HeJ mice had higher levels of apoE on both diets. The major response to consumption of the high fat diet for both strains was an increase in apoB-48 from 5 micrograms/ml on a low fat diet to 54 and 109 micrograms/ml for C57BL/6J and C3H/HeJ, respectively. ApoB-100 showed minimal response to the high fat diet. The defined high fat diet can be used to study atherosclerosis in the mouse since it produces aortic lesions but reduces or eliminates other pathological changes such as gallstone formation and liver damage.
This article has been cited by other articles:
![]() |
Z. Su, S.-w. Tsaih, J. Szatkiewicz, Y. Shen, and B. Paigen Candidate genes for plasma triglyceride, FFA, and glucose revealed from an intercross between inbred mouse strains NZB/B1NJ and NZW/LacJ J. Lipid Res., July 1, 2008; 49(7): 1500 - 1510. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Desai, M. M. Mariscalco, A. Tawil, J. G. Vallejo, and C. W. Smith Atherogenic diet-induced hepatitis is partially dependent on murine TLR4 J. Leukoc. Biol., June 1, 2008; 83(6): 1336 - 1344. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Bang, S. Bro, E. D. Bartels, T. X. Pedersen, and L. B. Nielsen Effect of uremia on HDL composition, vascular inflammation, and atherosclerosis in wild-type mice Am J Physiol Renal Physiol, October 1, 2007; 293(4): F1325 - F1331. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Jackson, M. R. Bennett, E. A.L. Biessen, J. L. Johnson, and R. Krams Assessment of Unstable Atherosclerosis in Mice Arterioscler. Thromb. Vasc. Biol., April 1, 2007; 27(4): 714 - 720. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Out, M. Hoekstra, I. Meurs, P. de Vos, J. Kuiper, M. Van Eck, and T. J.C. Van Berkel Total Body ABCG1 Expression Protects Against Early Atherosclerotic Lesion Development in Mice Arterioscler. Thromb. Vasc. Biol., March 1, 2007; 27(3): 594 - 599. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. S. M. Boesten, A. S. M. Zadelaar, A. van Nieuwkoop, L. Hu, J. Jonkers, B. van de Water, M. J. J. Gijbels, I. van der Made, M. P. J. de Winther, L. M. Havekes, et al. Macrophage retinoblastoma deficiency leads to enhanced atherosclerosis development in ApoE-deficient mice FASEB J, May 1, 2006; 20(7): 953 - 955. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. da Cunha, B. Martin-McNulty, J. Vincelette, L. Zhang, J. C. Rutledge, D. W. Wilson, R. Vergona, M. E. Sullivan, and Y.-X. Wang Interaction between mild hypercholesterolemia, HDL-cholesterol levels, and angiotensin II in intimal hyperplasia in mice J. Lipid Res., March 1, 2006; 47(3): 476 - 483. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. S. Getz and C. A. Reardon Diet and Murine Atherosclerosis Arterioscler. Thromb. Vasc. Biol., February 1, 2006; 26(2): 242 - 249. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. M. van den Berg, J. A. E. Spaan, T. M. Rolf, and H. Vink Atherogenic region and diet diminish glycocalyx dimension and increase intima-to-media ratios at murine carotid artery bifurcation Am J Physiol Heart Circ Physiol, February 1, 2006; 290(2): H915 - H920. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. van Erpecum, D. Q-H. Wang, A. Moschetta, D. Ferri, M. Svelto, P. Portincasa, J.-J. Hendrickx, M. Schipper, and G. Calamita Gallbladder histopathology during murine gallstone formation: relation to motility and concentrating function J. Lipid Res., January 1, 2006; 47(1): 32 - 41. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. B. Gurley, S. E. Clare, K. P. Snow, A. Hu, T. W. Meyer, and T. M. Coffman Impact of genetic background on nephropathy in diabetic mice Am J Physiol Renal Physiol, January 1, 2006; 290(1): F214 - F222. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Tabibiazar, R. A. Wagner, E. A. Ashley, J. Y. King, R. Ferrara, J. M. Spin, D. A. Sanan, B. Narasimhan, R. Tibshirani, P. S. Tsao, et al. Signature patterns of gene expression in mouse atherosclerosis and their correlation to human coronary disease Physiol Genomics, July 14, 2005; 22(2): 213 - 226. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. S.M. Boesten, A. S. M. Zadelaar, A. van Nieuwkoop, M. J.J. Gijbels, M. P.J. de Winther, L. M. Havekes, and B. J.M. van Vlijmen Tumor necrosis factor-{alpha} promotes atherosclerotic lesion progression in APOE*3-leiden transgenic mice Cardiovasc Res, April 1, 2005; 66(1): 179 - 185. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Ishimori, R. Li, P. M. Kelmenson, R. Korstanje, K. A. Walsh, G. A. Churchill, K. Forsman-Semb, and B. Paigen Quantitative trait loci that determine plasma lipids and obesity in C57BL/6J and 129S1/SvImJ inbred mice J. Lipid Res., September 1, 2004; 45(9): 1624 - 1632. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Van Eck, I. S. T. Bos, R. B. Hildebrand, B. T. Van Rij, and T. J.C. Van Berkel Dual Role for Scavenger Receptor Class B, Type I on Bone Marrow-Derived Cells in Atherosclerotic Lesion Development Am. J. Pathol., September 1, 2004; 165(3): 785 - 794. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Korstanje, R. Li, T. Howard, P. Kelmenson, J. Marshall, B. Paigen, and G. Churchill Influence of sex and diet on quantitative trait loci for HDL cholesterol levels in an SM/J by NZB/BlNJ intercross population J. Lipid Res., May 1, 2004; 45(5): 881 - 888. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Korstanje, J. J. Albers, G. Wolfbauer, R. Li, A.-Y. Tu, G. A. Churchill, and B. J. Paigen Quantitative Trait Locus Mapping of Genes That Regulate Phospholipid Transfer Activity in SM/J and NZB/BlNJ Inbred Mice Arterioscler. Thromb. Vasc. Biol., January 1, 2004; 24(1): 155 - 160. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Ishimori, R. Li, P. M. Kelmenson, R. Korstanje, K. A. Walsh, G. A. Churchill, K. Forsman-Semb, and B. Paigen Quantitative Trait Loci Analysis for Plasma HDL-Cholesterol Concentrations and Atherosclerosis Susceptibility Between Inbred Mouse Strains C57BL/6J and 129S1/SvImJ Arterioscler. Thromb. Vasc. Biol., January 1, 2004; 24(1): 161 - 166. [Abstract] [Full Text] [PDF] |
||||
![]() |
G.-Z. Tao, D. M. Toivola, B. Zhong, S. A. Michie, E. Z. Resurreccion, Y. Tamai, M. M. Taketo, and M. B. Omary Keratin-8 null mice have different gallbladder and liver susceptibility to lithogenic diet-induced injury J. Cell Sci., November 15, 2003; 116(22): 4629 - 4638. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Vergnes, J. Phan, M. Strauss, S. Tafuri, and K. Reue Cholesterol and Cholate Components of an Atherogenic Diet Induce Distinct Stages of Hepatic Inflammatory Gene Expression J. Biol. Chem., October 31, 2003; 278(44): 42774 - 42784. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Allayee, A. Ghazalpour, and A. J. Lusis Using Mice to Dissect Genetic Factors in Atherosclerosis Arterioscler. Thromb. Vasc. Biol., September 1, 2003; 23(9): 1501 - 1509. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Wang, I. Le Roy, E. Nicodeme, R. Li, R. Wagner, C. Petros, G. A. Churchill, S. Harris, A. Darvasi, J. Kirilovsky, et al. Using Advanced Intercross Lines for High-Resolution Mapping of HDL Cholesterol Quantitative Trait Loci Genome Res., July 1, 2003; 13(7): 1654 - 1664. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Gulledge, C. McShea, T. Schwartz, G. Koch, and S. T. Lord Effects of Hyperfibrinogenemia on Vasculature of C57BL/6 Mice With and Without Atherogenic Diet Arterioscler. Thromb. Vasc. Biol., January 1, 2003; 23(1): 130 - 135. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. A. Pitman, R. Korstanje, G. A. Churchill, E. Nicodeme, J. J. Albers, M. C. Cheung, M. A. Staton, S. S. Sampson, S. Harris, and B. Paigen Quantitative trait locus mapping of genes that regulate HDL cholesterol in SM/J and NZB/B1NJ inbred mice Physiol Genomics, May 10, 2002; 9(2): 93 - 102. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Devlin, G. Kuriakose, E. Hirsch, and I. Tabas Genetic alterations of IL-1 receptor antagonist in mice affect plasma cholesterol level and foam cell lesion size PNAS, April 30, 2002; 99(9): 6280 - 6285. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Van Eck, I. S. T. Bos, W. E. Kaminski, E. Orso, G. Rothe, J. Twisk, A. Bottcher, E. S. Van Amersfoort, T. A. Christiansen-Weber, W.-P. Fung-Leung, et al. Leukocyte ABCA1 controls susceptibility to atherosclerosis and macrophage recruitment into tissues PNAS, April 30, 2002; 99(9): 6298 - 6303. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Furbee Jr., J. K. Sawyer, and J. S. Parks Lecithin:Cholesterol Acyltransferase Deficiency Increases Atherosclerosis in the Low Density Lipoprotein Receptor and Apolipoprotein E Knockout Mice J. Biol. Chem., January 25, 2002; 277(5): 3511 - 3519. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Lutgens, E. D. de Muinck, S. Heeneman, and M. J.A.P. Daemen Compensatory Enlargement and Stenosis Develop in ApoE-/- and ApoE*3-Leiden Transgenic Mice Arterioscler. Thromb. Vasc. Biol., August 1, 2001; 21(8): 1359 - 1365. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. M. Delsing, E. H. Offerman, W. van Duyvenvoorde, H. van der Boom, E. C. M. de Wit, M. J. J. Gijbels, A. van der Laarse, J. W. Jukema, L. M. Havekes, and H. M. G. Princen Acyl-CoA:Cholesterol Acyltransferase Inhibitor Avasimibe Reduces Atherosclerosis in Addition to Its Cholesterol-Lowering Effect in ApoE*3-Leiden Mice Circulation, April 3, 2001; 103(13): 1778 - 1786. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Fosslien Mitochondrial Medicine - Molecular Pathology of Defective Oxidative Phosphorylation Ann. Clin. Lab. Sci., January 1, 2001; 31(1): 25 - 67. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Friedman, A. Ben-Yehuda, Y. Dabach, G. Hollander, S. Babaey, M. Ben-Naim, O. Stein, and Y. Stein Macrophage Cholesterol Metabolism, Apolipoprotein E, and Scavenger Receptor AI/II mRNA in Atherosclerosis-Susceptible and -Resistant Mice Arterioscler. Thromb. Vasc. Biol., November 1, 2000; 20(11): 2459 - 2464. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Herijgers, M. P. J. de Winther, M. Van Eck, L. M. Havekes, M. H. Hofker, P. M. Hoogerbrugge, and T. J. C. Van Berkel Effect of human scavenger receptor class A overexpression in bone marrow-derived cells on lipoprotein metabolism and atherosclerosis in low density lipoprotein receptor knockout mice J. Lipid Res., September 1, 2000; 41(9): 1402 - 1409. [Abstract] [Full Text] |
||||
![]() |
M. Van Eck, R. Zimmermann, P. H. E. Groot, R. Zechner, and T. J. C. Van Berkel Role of Macrophage-Derived Lipoprotein Lipase in Lipoprotein Metabolism and Atherosclerosis Arterioscler. Thromb. Vasc. Biol., September 1, 2000; 20 (9): e53 - e62. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Herijgers, M. Van Eck, P. H. E. Groot, P. M. Hoogerbrugge, and T. J. C. Van Berkel Low Density Lipoprotein Receptor of Macrophages Facilitates Atherosclerotic Lesion Formation in C57Bl/6 Mice Arterioscler. Thromb. Vasc. Biol., August 1, 2000; 20(8): 1961 - 1967. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. M. Dong, A. A. Brown, and D. D. Wagner Prominent Role of P-Selectin in the Development of Advanced Atherosclerosis in ApoE-Deficient Mice Circulation, May 16, 2000; 101(19): 2290 - 2295. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Q-H. Wang, F. Lammert, B. Paigen, and M. C. Carey Phenotypic characterization of Lith genes that determine susceptibility to cholesterol cholelithiasis in inbred mice: pathophysiology of biliary lipid secretion J. Lipid Res., November 1, 1999; 40(11): 2066 - 2079. [Abstract] [Full Text] |
||||
![]() |
F. Lammert, D. Q-H. Wang, B. Paigen, and M. C. Carey Phenotypic characterization of Lith genes that determine susceptibility to cholesterol cholelithiasis in inbred mice: integrated activities of hepatic lipid regulatory enzymes J. Lipid Res., November 1, 1999; 40(11): 2080 - 2090. [Abstract] [Full Text] |
||||
![]() |
A. H. Lichtman, S. K. Clinton, K. Iiyama, P. W. Connelly, P. Libby, and M. I. Cybulsky Hyperlipidemia and Atherosclerotic Lesion Development in LDL Receptor–Deficient Mice Fed Defined Semipurified Diets With and Without Cholate Arterioscler. Thromb. Vasc. Biol., August 1, 1999; 19(8): 1938 - 1944. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Ueda, L. Royer, E. Gong, J. Zhang, P. N. Cooper, O. Francone, and E. M. Rubin Lower Plasma Levels and Accelerated Clearance of High Density Lipoprotein (HDL) and Non-HDL Cholesterol in Scavenger Receptor Class B Type I Transgenic Mice J. Biol. Chem., March 12, 1999; 274(11): 7165 - 7171. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Q.-H. Wang, F. Lammert, D. E. Cohen, B. Paigen, and M. C. Carey Cholic acid aids absorption, biliary secretion, and phase transitions of cholesterol in murine cholelithogenesis Am J Physiol Gastrointest Liver Physiol, March 1, 1999; 276(3): G751 - G760. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Albers, W. Pitman, G. Wolfbauer, M. C. Cheung, H. Kennedy, A.-Y. Tu, S. M. Marcovina, and B. Paigen Relationship between phospholipid transfer protein activity and HDL level and size among inbred mouse strains J. Lipid Res., February 1, 1999; 40(2): 295 - 301. [Abstract] [Full Text] |
||||
![]() |
E. Lutgens, M. Daemen, M. Kockx, P. Doevendans, M. Hofker, L. Havekes, H. Wellens, and E. D. de Muinck Atherosclerosis in APOE*3-Leiden Transgenic Mice : From Proliferative to Atheromatous Stage Circulation, January 19, 1999; 99(2): 276 - 283. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Kim, P. Ambroziak, M. M. Veniant, R. L. Hamilton, and S. G. Young A Gene-targeted Mouse Model for Familial Hypobetalipoproteinemia. LOW LEVELS OF APOLIPOPROTEIN B mRNA IN ASSOCIATION WITH A NONSENSE MUTATION IN EXON 26 OF THE APOLIPOPROTEIN B GENE J. Biol. Chem., December 18, 1998; 273(51): 33977 - 33984. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Cynshi, Y. Kawabe, T. Suzuki, Y. Takashima, H. Kaise, M. Nakamura, Y. Ohba, Y. Kato, K. Tamura, A. Hayasaka, et al. Antiatherogenic effects of the antioxidant BO-653 in three different animal models PNAS, August 18, 1998; 95(17): 10123 - 10128. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. M. van Vlijmen, R. P. Mensink, H. B. van 't Hof, R. F. G. Offermans, M. H. Hofker, and L. M. Havekes Effects of dietary fish oil on serum lipids and VLDL kinetics in hyperlipidemic apolipoprotein E*3-Leiden transgenic mice J. Lipid Res., June 1, 1998; 39(6): 1181 - 1188. [Abstract] [Full Text] |
||||
![]() |
E. A. Kirk, P. Sutherland, S. A. Wang, A. Chait, and R. C. LeBoeuf Dietary Isoflavones Reduce Plasma Cholesterol and Atherosclerosis in C57BL/6 Mice but not LDL Receptor-Deficient Mice J. Nutr., June 1, 1998; 128(6): 954 - 959. [Abstract] [Full Text] |
||||
![]() |
E. Kim and S. G. Young Genetically modified mice for the study of apolipoprotein B J. Lipid Res., April 1, 1998; 39(4): 703 - 723. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. A. Pitman, M. H. Hunt, C. McFarland, and B. Paigen Genetic Analysis of the Difference in Diet-Induced Atherosclerosis Between the Inbred Mouse Strains SM/J and NZB/BlNJ Arterioscler. Thromb. Vasc. Biol., April 1, 1998; 18(4): 615 - 620. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Munday, K. G. Thompson, K. A. C. James, and B. W. Manktelow Dietary Antioxidants Do Not Reduce Fatty Streak Formation in the C57BL/6 Mouse Atherosclerosis Model Arterioscler. Thromb. Vasc. Biol., January 1, 1998; 18(1): 114 - 119. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. Chiu, J. F. Oram, R. C. LeBoeuf, C. E. Alpers, and K. D. O'Brien High-Density Lipoprotein-Binding Protein (HBP)/Vigilin Is Expressed in Human Atherosclerotic Lesions and Colocalizes With Apolipoprotein E Arterioscler. Thromb. Vasc. Biol., November 1, 1997; 17(11): 2350 - 2358. [Abstract] [Full Text] |
||||
![]() |
M. Van Eck, N. Herijgers, J. Yates, N. J. Pearce, P. M. Hoogerbrugge, P. H. E. Groot, and T. J. C. Van Berkel Bone Marrow Transplantation in Apolipoprotein E–Deficient Mice : Effect of ApoE Gene Dosage on Serum Lipid Concentrations, (ß)VLDL Catabolism, and Atherosclerosis Arterioscler. Thromb. Vasc. Biol., November 1, 1997; 17(11): 3117 - 3126. [Abstract] [Full Text] |
||||
![]() |
S. D. Hughes, J. Verstuyft, and E. M. Rubin HDL Deficiency in Genetically Engineered Mice Requires Elevated LDL to Accelerate Atherogenesis Arterioscler. Thromb. Vasc. Biol., September 1, 1997; 17(9): 1725 - 1729. [Abstract] [Full Text] |
||||
![]() |
D. M. Levine and K. J. Williams Automated measurement of mouse apolipoprotein B: convenient screening tool for mouse models of atherosclerosis Clin. Chem., April 1, 1997; 43(4): 669 - 674. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Sakai, B. L. Vaisman, C. A. Koch, R. F. Hoyt Jr., S. M. Meyn, G. D. Talley, J. A. Paiz, H. B. Brewer Jr., and S. Santamarina-Fojo Targeted Disruption of the Mouse Lecithin:Cholesterol Acyltransferase (LCAT) Gene. GENERATION OF A NEW ANIMAL MODEL FOR HUMAN LCAT DEFICIENCY J. Biol. Chem., March 14, 1997; 272(11): 7506 - 7510. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. L. Hendriks, F. van der Sman-de Beer, B. J.M. van Vlijmen, L. C. van Vark, M. H. Hofker, and L. M. Havekes Uptake by J774 Macrophages of Very-Low-Density Lipoproteins Isolated From ApoE-Deficient Mice Is Mediated by a Distinct Receptor and Stimulated by Lipoprotein Lipase Arterioscler. Thromb. Vasc. Biol., March 1, 1997; 17(3): 498 - 504. [Abstract] [Full Text] |
||||
![]() |
B. J.M. van Vlijmen, K. W. van Dijk, H. B. van't Hof, P. J.J. van Gorp, A. van der Zee, H. van der Boom, M. L. Breuer, M. H. Hofker, and L. M. Havekes In the Absence of Endogenous Mouse Apolipoprotein E, Apolipoprotein E*2(Arg-158 right-arrow Cys) Transgenic Mice Develop More Severe Hyperlipoproteinemia than Apolipoprotein E*3-Leiden Transgenic Mice J. Biol. Chem., November 29, 1996; 271(48): 30595 - 30602. [Abstract] [Full Text] [PDF] |
||||
![]() |
|